These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6131604)

  • 21. Enhanced alpha-adrenergic responsiveness in ischemic myocardium: role of alpha-adrenergic blockade.
    Corr PB; Crafford WA
    Am Heart J; 1981 Sep; 102(3 Pt 2):605-12. PubMed ID: 6115577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pharmacology of adrenergic neuronal responses in the cerebral cortex: evidence for excitatory alpha- and inhibitory beta-receptors.
    Bevan P; Bradshaw CM; Szabadi E
    Br J Pharmacol; 1977 Apr; 59(4):635-41. PubMed ID: 15697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of alpha adrenergic blockade and tissue catecholamine depletion on pulmonary vascular response to hypoxia.
    Silove ED; Grover RF
    J Clin Invest; 1968 Feb; 47(2):274-85. PubMed ID: 12066776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sympathetic activity and presynaptic adrenoceptor function in patients with longstanding essential hypertension.
    Chang PC; Kriek E; van Brummelen P
    J Hypertens; 1994 Feb; 12(2):179-90. PubMed ID: 8021470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of antihypertensive therapies on the sympathetic nervous system.
    de Champlain J; Karas M; Toal C; Nadeau R; Larochelle P
    Can J Cardiol; 1999 Mar; 15 Suppl A():8A-14A. PubMed ID: 10205251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postjunctional alpha-adrenoceptors in the rabbit isolated distal saphenous artery: indirect sensitivity to prazosin of responses to noradrenaline mediated via postjunctional alpha 2-adrenoceptors.
    Dunn WR; McGrath JC; Wilson VG
    Br J Pharmacol; 1991 Jun; 103(2):1484-92. PubMed ID: 1679360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pharmacological basis for the use of alpha 1-adrenoceptor antagonists in the treatment of essential hypertension.
    Davey MJ
    Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):5S-8S. PubMed ID: 2871856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between density of alpha-adrenoceptor binding sites and contractile responses in several porcine isolated blood vessels.
    Wright IK; Blaylock NA; Kendall DA; Wilson VG
    Br J Pharmacol; 1995 Feb; 114(3):678-88. PubMed ID: 7735695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in reactivity of visceral resistive and capacitive vessels during adaptation to high mountain conditions.
    Polenov SA; Chernyavskaya GV; Daniyarov SB; Tkachenko BI
    Hum Physiol; 1978; 4(3):380-4. PubMed ID: 38203
    [No Abstract]   [Full Text] [Related]  

  • 30. Alpha 1- and alpha 2-adrenoceptors: pharmacology and clinical implications.
    Starke K; Docherty JR
    J Cardiovasc Pharmacol; 1981; 3 Suppl 1():S14-23. PubMed ID: 6169956
    [No Abstract]   [Full Text] [Related]  

  • 31. [Alpha-adrenergic control of kidney function. Its significance for the pathogenesis and treatment of arterial hypertension].
    Pir'ova B
    Vutr Boles; 1987; 26(6):12-8. PubMed ID: 2894096
    [No Abstract]   [Full Text] [Related]  

  • 32. Combined alpha- and beta-adrenergic blockade in the treatment of hypertension. Introductory remarks: alpha- and beta-adrenergic receptors and the cardiovascular system.
    Vanhoutte PM
    J Cardiovasc Pharmacol; 1981; 3 Suppl 1():S1-13. PubMed ID: 6169954
    [No Abstract]   [Full Text] [Related]  

  • 33. Adrenergic receptors: biochemistry, regulation, molecular mechanism, and clinical implications.
    Heinsimer JA; Lefkowitz RJ
    J Lab Clin Med; 1982 Nov; 100(5):641-58. PubMed ID: 6127370
    [No Abstract]   [Full Text] [Related]  

  • 34. Alpha-adrenergic blockers: mechanism of action, blood pressure control, and effects of lipoprotein metabolism.
    Nash DT
    Clin Cardiol; 1990 Nov; 13(11):764-72. PubMed ID: 1980236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relation between adrenergic neurogenic contraction and alpha 1-adrenoceptor subtypes in dog mesenteric and carotid arteries and rabbit carotid arteries.
    Muramatsu I
    Br J Pharmacol; 1991 Jan; 102(1):210-4. PubMed ID: 1675144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review of the use of alpha-adrenoceptor antagonists in hypertension.
    Stokes GS; Marwood JF
    Methods Find Exp Clin Pharmacol; 1984 Apr; 6(4):197-204. PubMed ID: 6146746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Smooth muscle alpha-2 adrenoceptors mediate vasoconstrictor responses to exogenous norepinephrine and to sympathetic stimulation to a greater extent in spontaneously hypertensive than in Wistar Kyoto rat tail arteries.
    Medgett IC; Hicks PE; Langer SZ
    J Pharmacol Exp Ther; 1984 Oct; 231(1):159-65. PubMed ID: 6149302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of the sympathetic nervous system in hypertension and benign prostatic hyperplasia.
    Pool JL
    Br J Clin Pract Suppl; 1994 May; 74():13-7. PubMed ID: 7519436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacologic and therapeutic significance of alpha-adrenoceptor subtypes.
    Langer SZ; Duval N; Massingham R
    J Cardiovasc Pharmacol; 1985; 7 Suppl 8():S1-8. PubMed ID: 2417042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The human adrenergic neurovascular mechanism.
    Bevan JA
    Gen Pharmacol; 1983; 14(1):21-6. PubMed ID: 6131010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.